We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
CareGREEN is an innovation company that has created a unique air pollution capture and storage technology with the aim to reduce harmful pollution in the atmosphere. Their latest product is the Environmental Air Purification Intervention & Control System (EAPICS). The technology has been accredited as a significant solution in reducing COx worldwide. A World Health Organisation (2016) report established that more than 80% of people living in urban areas face the greatest environmental risk to their health today due to air pollution. CareGREEN believes its specialised filtration systems will contribute to a considerable fall in health issues linked to poor air quality. It is also diversifying its reach in other renewable energy sectors such as solar and wind. The company will utilise the investment to scale its business.
days to go: Expired investment: Withheld
Cellmed is an immuno-oncology company that are developing treatments for ovarian cancer.  Their lead product PROCURE a dendritic cell vaccine and they are now looking to expand the treatment to target solid tumors.    
days to go: Expired investment: £520,294
Combat Medical have created an innovative method to treat bladder cancer by using heated chemotherapy. By heating the treatment the membrane is more permeable and is able to penetrate further. 
days to go: Expired investment: £1,725,220
CoreHaus applies known, tried and tested construction methodology intelligently to meet the growing demand for offsite manufactured housing solutions. Their principles are based on ground and the first floor standardised 'modular cores' which includes a pre-finished kitchen, staircase, central heating and electrical control systems and bathroom. Their product has designed and developed, trademarks and IP's are in place, private sites secured under contract, and they are currently working with some exciting partners and supply chains to roll out the product launch.
days to go: Expired investment: Withheld
Co-Space is a forward-thinking flexible office operator with a focus on affluent towns and cities outside Central London. Established in 2018, Co-Space has thrived even during the pandemic, boasting two successful sites in Reading (95% occupied) and Stevenage (93% occupied). Our approach involves transforming underutilized spaces into highly sought-after flexible offices, incorporating exceptional interior design and dedicated service. With a revenue run rate of £1.5 million and over 90% of it being contracted and recurring, Co-Space is a promising contender, bridging the gap between exceptional London design and regional competition.
days to go: Expired investment: £50,000
CrowdProperty is a specialist property project lending platform that matches quality property professionals undertaking quality property projects with institutional/private investors of capital for value-creating property projects. It seeks to ensure profits for borrowers, lenders, the under-supplied UK housing environment, and the UK economy through its business model. The company claims to have recently closed a £300 million funding line from a global asset manager. It has lent upwards of £140 million with £180 million+ originated facilities, gained recognition by Deloitte Fast50 and FT1000 as a 'High Growth Business', and built a proprietary and scalable technology platform. CrowdProperty has also launched CrowdProperty Australia, leveraging its asset-class expertise, scalable proprietary technology and IP from the UK business in the Australian market. The company states it will use the investment to grow its property team, evolve its technology platform further, acquire more customers, and grow its business.
days to go: Expired investment: £1,815,319
Reducing the cost of orthopaedic equipment by using compression screws and titanium maxiangle locking plates. DC Surgical Supplies have acquired an exclusive license with Palmer & Baker with the aim of helping the NHS cut the cost of purchasing regular-use equipment by as much as 35%. Their product is CE Certified and has been featured in The Telegraph.
days to go: Expired investment: £99,000
Providing dental professionals with an online Personal Development Plan for their Continuing Professional Development. Dentinal Tubules currently has more than 2,100 individuals registered to use the service and over 2,700 dental practice professionals that are paying for a subscription. Dentinal Tubules hosts more than 1,500 educational and certified videos to help with a professional's CPD, in addition they also offer live courses, a livestream and an annual congress. Investments will be used to enhance, develop and bring the technology in-house.
days to go: Expired investment: £155,820
A technological healthcare service allowing patients to discuss any concerns with a GP, clinician or specialists via video consultations, home visits, or appointments at the clinic. DocNoc launched less than 12 months ago and has over 160 NHS and private sector doctors and clinics registered on the service. The company's business model is easily flexible and aim to launch DocNoc internationally.
days to go: Expired investment: £269,710
One of the largest UK-based estate agents on the internet as listed by Which?, with 1 out of every 100 properties listed on their website. Doorsteps.co.uk have achieved this feat without spending any money on advertising since launching and instead through PR and word-of-mouth. Funds are being raised to increase staffing levels to meet customer demand and provide higher quality services using a combination of technology and real-life agents.
days to go: Expired investment: £889,340
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph